Rise of Biologics
Biologic therapies have significantly transformed patient care, especially in oncology, immunology, and rare diseases. This discussion will focus on the latest advancements in biologics, including the development of monoclonal antibodies and breakthroughs in gene therapy. Challenges in biologic drug development and the emergence of biosimilar will also be examined, along with the potential of combination therapies to enhance treatment efficacy.